Alloxan acts as a prooxidant only under reducing conditions:: influence of melatonin

被引:36
作者
Brömme, HJ
Ebelt, H
Peschke, D
Peschke, E
机构
[1] Univ Halle Wittenberg, Inst Anat & Cell Biol, D-06097 Halle, Germany
[2] Univ Halle Wittenberg, Inst Pathophysiol, D-06097 Halle, Germany
关键词
alloxan; free radicals; oxidative stress; diabetes; melatonin; antioxidant; prooxidant; lucigenin; NBT;
D O I
10.1007/s000180050305
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Depending on the availability of suitable reducing agents, alloxan can be either a prooxidant or an antioxidant. Alloxan and its reduced derivative, dialuric acid, act as a redox couple, driven by reduced glutathione (GSH) or L-cysteine, generating in vitro in the presence of oxygen, both superoxide radical and hydrogen peroxide. The production of superoxide radicals was shown by the appearance of lucigenin chemiluminescence (CL) as well as by the generation of formazan from nitroblue tetrazolium (NBT). The lucigenin CL as well as the NET reduction was inhibited by superoxide dismutase and partially by catalase. Melatonin inhibited alloxan-mediated CL. In contrast, in the absence of reducing agents, alloxan is a scavenger of superoxide radicals formed by other reactions. Because of the high content of reducing compounds in the cell (e.g. glutathione), it is suggested that alloxan acts in vivo mainly as a generator of reactive oxygen species.
引用
收藏
页码:487 / 493
页数:7
相关论文
共 33 条
[1]   CHEMI-LUMINESCENCE AS AN INDEX OF DRUG-INDUCED FREE-RADICAL PRODUCTION IN PANCREATIC-ISLETS [J].
ASAYAMA, K ;
ENGLISH, D ;
SLONIM, AE ;
BURR, IM .
DIABETES, 1984, 33 (02) :160-163
[2]   THE PLASMA-VOLUME OF THE WISTAR RAT IN RELATION TO THE BODY-WEIGHT [J].
BIJSTERBOSCH, MK ;
DUURSMA, AM ;
BOUMA, JMW ;
GRUBER, M .
EXPERIENTIA, 1981, 37 (04) :381-382
[3]  
BROMME HJ, 1999, IN PRESS VERH ANAT S, V181
[4]  
EBELT H, 1998, VERH ANAT GES S, V180, P99
[5]  
ELFERINK JGR, 1984, RES COMMUN CHEM PATH, V43, P339
[6]   LUMINOL AND LUCIGENIN AS DETECTORS FOR O2.- [J].
FAULKNER, K ;
FRIDOVICH, I .
FREE RADICAL BIOLOGY AND MEDICINE, 1993, 15 (04) :447-451
[7]  
FRERICHS H, 1971, HDB EXPT PHARM, V32, P159
[8]  
Gorus FK, 1982, BIOCHEM J, V208, P313
[9]   LUCIGENIN CHEMILUMINESCENCE IN THE ASSESSMENT OF NEUTROPHIL SUPEROXIDE PRODUCTION [J].
GYLLENHAMMAR, H .
JOURNAL OF IMMUNOLOGICAL METHODS, 1987, 97 (02) :209-213
[10]  
HEIM KF, 1991, J PHARMACOL EXP THER, V256, P537